Cytokinetics Inc (CYTK)
60.42
-0.18
(-0.30%)
USD |
NASDAQ |
May 21, 13:31
Cytokinetics Shares Outstanding: 104.85M for May 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 08, 2024 | 104.85M |
March 31, 2024 | 104.77M |
March 26, 2024 | 104.58M |
February 29, 2024 | 103.29M |
February 27, 2024 | 103.00M |
December 31, 2023 | 101.64M |
November 01, 2023 | 98.05M |
September 30, 2023 | 96.25M |
August 01, 2023 | 96.00M |
June 30, 2023 | 95.94M |
May 02, 2023 | 95.64M |
March 31, 2023 | 95.61M |
March 21, 2023 | 95.59M |
February 28, 2023 | 95.16M |
February 27, 2023 | 95.16M |
December 31, 2022 | 94.83M |
November 02, 2022 | 94.63M |
September 30, 2022 | 94.58M |
August 02, 2022 | 94.14M |
June 30, 2022 | 85.92M |
May 04, 2022 | 85.65M |
March 31, 2022 | 85.58M |
March 21, 2022 | 85.50M |
February 28, 2022 | 84.86M |
February 22, 2022 | 84.86M |
Date | Value |
---|---|
December 31, 2021 | 84.80M |
December 20, 2021 | 84.39M |
November 01, 2021 | 83.88M |
September 30, 2021 | 83.83M |
August 02, 2021 | 83.51M |
July 23, 2021 | 83.24M |
June 30, 2021 | 71.90M |
May 04, 2021 | 71.74M |
March 31, 2021 | 71.56M |
March 22, 2021 | 71.54M |
February 26, 2021 | 71.12M |
February 23, 2021 | 71.11M |
December 31, 2020 | 71.02M |
November 02, 2020 | 70.78M |
September 30, 2020 | 70.59M |
August 03, 2020 | 70.50M |
July 21, 2020 | 70.39M |
July 16, 2020 | 62.01M |
July 14, 2020 | 61.47M |
June 30, 2020 | 59.94M |
May 04, 2020 | 59.47M |
March 31, 2020 | 59.46M |
March 23, 2020 | 59.46M |
March 02, 2020 | 59.45M |
February 14, 2020 | 59.18M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
58.06M
Minimum
Jun 30 2019
104.85M
Maximum
May 08 2024
80.28M
Average
83.85M
Median
Shares Outstanding Benchmarks
Amgen Inc | 536.43M |
Johnson & Johnson | 2.407B |
Viking Therapeutics Inc | 110.27M |
Eli Lilly and Co | 950.41M |
Madrigal Pharmaceuticals Inc | 21.31M |